Derivative Liabilities - Fair Value
ResMed Derivative Liabilities - Fair Value increased by 13.6% to $145.39M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 204.2%, from $47.79M to $145.39M. Over 3 years (FY 2022 to FY 2025), Derivative Liabilities - Fair Value shows an upward trend with a 308.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase in liabilities suggests unfavorable market movements for the company's hedges, while a decrease indicates a reduction in potential settlement obligations.
Detailed definition
This represents the fair value of derivative financial instruments that are currently in a liability position. These lia...
Peer comparison
Standard for energy companies; peers with similar hedging profiles will show comparable volatility in this line item.
derivative_liabilities_fair_valueHistorical Data
| Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.95M | $40.02M | $61.59M | $70.70M | $52.85M | $72.61M | $46.39M | $36.54M | $74.73M | $18.23M | $47.79M | $132.82M | $136.73M | $127.96M | $145.39M |
| QoQ Change | — | >999% | +53.9% | +14.8% | -25.3% | +37.4% | -36.1% | -21.2% | +104.5% | -75.6% | +162.2% | +177.9% | +2.9% | -6.4% | +13.6% |
| YoY Change | — | — | — | >999% | — | +81.4% | -24.7% | -48.3% | +41.4% | -74.9% | +3.0% | +263.5% | +83.0% | +602.0% | +204.2% |
Derivative Liabilities - Fair Value at Other Companies
Frequently Asked Questions
- What is ResMed's derivative liabilities - fair value?
- ResMed (RMD) reported derivative liabilities - fair value of $145.39M in Q1 2026.
- How has ResMed's derivative liabilities - fair value changed year-over-year?
- ResMed's derivative liabilities - fair value increased by 204.2% year-over-year, from $47.79M to $145.39M.
- What is the long-term trend for ResMed's derivative liabilities - fair value?
- Over 3 years (2022 to 2025), ResMed's derivative liabilities - fair value has grown at a 308.6% compound annual growth rate (CAGR), from $1.95M to $132.82M.
- What does derivative liabilities - fair value mean?
- The total market value of all derivative contracts that are currently resulting in a loss.